Volume 59, Issue 5 pp. 1755-1764
CELLULAR THERAPIES

Effects of starting cellular material composition on chimeric antigen receptor T-cell expansion and characteristics

Nasha Elavia

Nasha Elavia

Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland

Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, Maryland

Co-first authors.Search for more papers by this author
Sandhya R. Panch

Sandhya R. Panch

Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland

Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, Maryland

Co-first authors.Search for more papers by this author
Andrew McManus

Andrew McManus

Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland

Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, Maryland

Search for more papers by this author
Thejaswi Bikkani

Thejaswi Bikkani

Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland

Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, Maryland

Search for more papers by this author
James Szymanski

James Szymanski

Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland

Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, Maryland

Search for more papers by this author
Steven L. Highfill

Steven L. Highfill

Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland

Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, Maryland

Search for more papers by this author
Ping Jin

Ping Jin

Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland

Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, Maryland

Search for more papers by this author
Jennifer Brudno

Jennifer Brudno

Experimental Transplantation and Immunology Branch, National Cancer Institute and National Institutes of Health, Bethesda, Maryland

Search for more papers by this author
James Kochenderfer

James Kochenderfer

Experimental Transplantation and Immunology Branch, National Cancer Institute and National Institutes of Health, Bethesda, Maryland

Search for more papers by this author
David F. Stroncek

Corresponding Author

David F. Stroncek

Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland

Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, Maryland

Address reprint requests to: David F. Stroncek, MD, Center for Cellular Engineering, NIH Clinical Center, 10 Center Drive – MSC-1184, Building 10, Room 1C711, Bethesda, MD 20892-1184; e-mail: [email protected]Search for more papers by this author
First published: 11 April 2019
Citations: 31
This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and the National Institutes of Health Clinical Center.

Abstract

BACKGROUND

When manufacturing chimeric antigen receptor (CAR) T cells using anti-CD3/anti-CD28 beads, ex vivo T-cell expansion is dependent on the composition of leukocytes used in the manufacturing process. We investigated the effects of leukocyte composition on CAR T-cell expansion and characteristics using an alternative manufacturing method.

METHODS

Anti–B-cell maturation antigen and CD19-CAR T cells were manufactured using autologous peripheral blood mononuclear cell (PBMNC) concentrates. The PBMNCs were enriched for lymphocytes using density gradient separation, which were used for CAR T-cell culture initiation. T-cell expansion was stimulated with soluble anti-CD3 and interleukin-2.

RESULTS

Fifty-one CAR T-cell products were evaluated; 28 anti–B-cell maturation antigen (BCMA) CAR T cells produced for 24 patients and 27 CD19 CAR T cells produced for 24 patients. CAR T-cell expansion was reduced when greater quantities of monocytes were present in the post–density gradient separation PBMNCs. In addition, the ratio of CD4 to CD8 cells in the CAR T-cell products after 7 days of culture was dependent on the quantity of monocytes, RBCs, and neutrophils in the post–density gradient separation PBMNCs. Greater quantities of monocytes and RBCs were associated with a greater proportion of CD4+ cells and greater quantities of neutrophils were associated with a greater proportion of CD8+ cells.

CONCLUSIONS

The composition of leukocytes used to manufacture CAR T cells can affect cell expansion and the composition of CAR T-cell products. More uniform or complete lymphocyte enrichment of PBMNCs improves the consistency of final CAR T-cell products.

CONFLICT OF INTEREST

The authors have disclosed no conflicts of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.